| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6007572 | Clinical Neurophysiology | 2016 | 9 Pages |
Abstract
As effective treatments become available, early identification of cognitive impairment can facilitate the prescription of treatment at the earliest juncture. CAEPs have the potential to serve as efficient, non-invasive, cost-effective indicators of future cognitive decline and impairment.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jennifer J. Lister, Aryn L. Harrison Bush, Ross Andel, Courtney Matthews, David Morgan, Jerri D. Edwards,